Skip to content

Mobile Health Intervention

Use of New Technologies for the Follow-up in Adolescent Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02955017
Acronym
MHI
Enrollment
91
Registered
2016-11-04
Start date
2016-11-16
Completion date
2019-11-13
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, children, adolescents, new technology, mobile health, chronic disease

Brief summary

The purpose of this study is to evaluate the efficacy of a distance follow-up on body mass index decrease at 15 months compared to traditional management in obese adolescents.

Detailed description

Childhood obesity continues to be a key challenge in France. The unit is facing a high demand with limited resources, moreover despite an intensive program of care with a multidisciplinary dedicated team, the impact on weight loss is moderate. The hypothesis is to ameliorate results by using distance monitoring in maintenance phase. After a traditional intensive period consisting in a weekly family-based multidisciplinary intervention, patients are randomized in two arms, traditional or distance follow-up. Traditional follow-up is based on face-to-face multidisciplinary consultations every three months. The distance monitoring is based on a mobile application dedicated to food behavior change and physical activity, with weekly self-monitoring, goal setting, physical activity and healthy eating support, monthly weight assessment. Pre-programmed feedbacks motivational strategies are included. After one year of follow-up, adolescents are evaluated for weight loss, compliance and quality of life. The two groups will be compared. The question is can mobile apps help to monitor and promote healthy lifestyle in obese adolescents.

Interventions

BEHAVIORALtraditional follow_up

* Multidisciplinary support with educational face to face family based intervention at 6, 9 and 12 months after inclusion. * Two days of a complete medical check at 9 and 15 months

BEHAVIORALdistance follow-up new technologies

* Multidisciplinary support with long distance monitoring Mobile apps. * Two days of a complete medical check at 9 and 15 months

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* 11-17 years old * Body Mass Index \> 97th percentile using French reference * Non Syndromic obesity * Appropriate understanding of the study * Appropriate understanding of french language, and ability in writing and reading

Exclusion criteria

* Mental disability, severe and uncontrolled psychiatric disorders. * Syndromic obesity, endocrine disorders or drug-induced obesity * Other therapeutic: bariatric surgery, medications for weight loss * Enrolment in an other therapeutic study

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Body Mass Index Z-score15 monthsBody mass index z score is calculated using french reference data. success: decrease of Body Mass Index Z-score from baseline to 15 months of 0.5 standard deviation

Secondary

MeasureTime frameDescription
Percent of loss to follow-up15 months
Change from baseline in PedsQL score15 months
Change from baseline in Eating Behavior assessed by a dietitian from a questionnaire15 months
Change from baseline in Physical activity and sedentary behavior assessed by the number of hours of physical activity per week15 months
Change from baseline in mean difference of Body Mass Index Z-score between the two groups15 months
Fasting insulinemia (µmol/l)15 monthsChange from baseline in metabolic syndrome
Homeostasis Model assessment (HOMA)15 monthsChange from baseline in metabolic syndrome
Dyslipidemia (mmol/l)15 monthsChange from baseline in metabolic syndrome
Blood pressure (mmHg)15 monthsChange from baseline in metabolic syndrome
Glycemia (mmol/l)15 monthsChange from baseline in metabolic syndrome

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026